147 related articles for article (PubMed ID: 26176272)
1. Prognostic impact of membranous ATP-binding cassette Sub-family G member 2 expression in patients with colorectal carcinoma after surgical resection.
Kang D; Park JM; Jung CK; Lee BI; Oh ST; Choi MG
Cancer Biol Ther; 2015; 16(10):1438-44. PubMed ID: 26176272
[TBL] [Abstract][Full Text] [Related]
2. Membranous ABCG2 expression in colorectal cancer independently correlates with shortened patient survival.
Wang X; Xia B; Liang Y; Peng L; Wang Z; Zhuo J; Wang W; Jiang B
Cancer Biomark; 2013; 13(2):81-8. PubMed ID: 23838136
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma.
Yuan Y; Yang Z; Miao X; Li D; Liu Z; Zou Q
Tumour Biol; 2015 Dec; 36(12):9961-8. PubMed ID: 26178481
[TBL] [Abstract][Full Text] [Related]
4. Expression of ABCG2 associated with tumor response in metastatic colorectal cancer patients receiving first-line FOLFOX therapy--preliminary evidence.
Lin PC; Lin HH; Lin JK; Lin CC; Yang SH; Li AF; Chen WS; Chang SC
Int J Biol Markers; 2013 Jun; 28(2):182-6. PubMed ID: 23558935
[TBL] [Abstract][Full Text] [Related]
5. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG
Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447
[TBL] [Abstract][Full Text] [Related]
7. Expression of ABC transporters is an unfavorable prognostic factor in laryngeal squamous cell carcinoma.
Shen B; Li D; Dong P; Gao S
Ann Otol Rhinol Laryngol; 2011 Dec; 120(12):820-7. PubMed ID: 22279954
[TBL] [Abstract][Full Text] [Related]
8. ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma.
Wang H; Luo F; Zhu Z; Xu Z; Huang X; Ma R; He H; Zhu Y; Shao K; Zhao J
BMC Cancer; 2017 Mar; 17(1):222. PubMed ID: 28347288
[TBL] [Abstract][Full Text] [Related]
9. ABCG2 expression is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma.
Tsunoda S; Okumura T; Ito T; Kondo K; Ortiz C; Tanaka E; Watanabe G; Itami A; Sakai Y; Shimada Y
Oncology; 2006; 71(3-4):251-8. PubMed ID: 17671398
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients.
Lee SH; Kim H; Hwang JH; Lee HS; Cho JY; Yoon YS; Han HS
Pathol Int; 2012 Mar; 62(3):167-75. PubMed ID: 22360504
[TBL] [Abstract][Full Text] [Related]
11. Expression of ABCG2 and its significance in colorectal cancer.
Liu HG; Pan YF; You J; Wang OC; Huang KT; Zhang XH
Asian Pac J Cancer Prev; 2010; 11(4):845-8. PubMed ID: 21133588
[TBL] [Abstract][Full Text] [Related]
12. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
13. Expression of ABCG2 and Bmi-1 in oral potentially malignant lesions and oral squamous cell carcinoma.
Dalley AJ; Pitty LP; Major AG; Abdulmajeed AA; Farah CS
Cancer Med; 2014 Apr; 3(2):273-83. PubMed ID: 24415717
[TBL] [Abstract][Full Text] [Related]
14. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
[TBL] [Abstract][Full Text] [Related]
15. ABCG2 is associated with HER-2 expression, lymph node metastasis and clinical stage in breast invasive ductal carcinoma.
Xiang L; Su P; Xia S; Liu Z; Wang Y; Gao P; Zhou G
Diagn Pathol; 2011 Sep; 6():90. PubMed ID: 21943250
[TBL] [Abstract][Full Text] [Related]
16. ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG
Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795
[TBL] [Abstract][Full Text] [Related]
17. ABCG2/V-ATPase was associated with the drug resistance and tumor metastasis of esophageal squamous cancer cells.
Huang L; Lu Q; Han Y; Li Z; Zhang Z; Li X
Diagn Pathol; 2012 Dec; 7():180. PubMed ID: 23244569
[TBL] [Abstract][Full Text] [Related]
18. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of ABCG2 in moderately and poorly differentiated intrahepatic cholangiocarcinoma.
Larbcharoensub N; Sornmayura P; Sirachainan E; Wilasrusmee C; Wanmoung H; Janvilisri T
Histopathology; 2011 Aug; 59(2):235-46. PubMed ID: 21884202
[TBL] [Abstract][Full Text] [Related]
20. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
To KK; Leung WW; Ng SS
Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]